A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

Background and Aims: Colon cancer can occur sporadically or in the setting of chronic inflammation, such as in patients with inflammatory bowel disease. We previously showed that A20, a critical negative regulator of tumor necrosis factor signal transduction, could regulate sporadic colon cancer dev...

Full description

Bibliographic Details
Main Authors: David W. Basta, Mandy Vong, Adolat Beshimova, Brooke N. Nakamura, Iulia Rusu, Michael G. Kattah, Ling Shao
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Gastro Hep Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S277257232200156X
_version_ 1798022570900979712
author David W. Basta
Mandy Vong
Adolat Beshimova
Brooke N. Nakamura
Iulia Rusu
Michael G. Kattah
Ling Shao
author_facet David W. Basta
Mandy Vong
Adolat Beshimova
Brooke N. Nakamura
Iulia Rusu
Michael G. Kattah
Ling Shao
author_sort David W. Basta
collection DOAJ
description Background and Aims: Colon cancer can occur sporadically or in the setting of chronic inflammation, such as in patients with inflammatory bowel disease. We previously showed that A20, a critical negative regulator of tumor necrosis factor signal transduction, could regulate sporadic colon cancer development. In this report, we investigate whether A20 also acts as a tumor suppressor in a model of colitis-associated cancer. Methods: Colitis and colitis-associated tumors were induced in wild-type and A20 intestinal epithelial cell-specific knockout (A20dIEC) mice using dextran sodium sulfate and azoxymethane. Clinicopathologic markers of inflammation were assessed in conjunction with colonic tumor burden. Gene expression analyses and immunohistochemistry were performed on colonic tissue and intestinal enteroids. Nitric oxide (NO) production and activity were assessed in whole colonic lysates and mouse embryonic fibroblasts. Results: A20dIEC mice develop larger tumors after treatment with dextran sodium sulfate and azoxymethane than wild-type mice. In addition to elevated markers of inflammation, A20dIEC mice have significantly enhanced expression of inducible nitric oxide synthase (iNOS), a well-known driver of neoplasia. Enhanced iNOS expression is associated with the formation of reactive nitrogen species and DNA damage. Loss of A20 also enhances NO-dependent cell death directly. Conclusion: Mechanistically, we propose that A20 normally restricts tumor necrosis factor–induced nuclear factor kappa B–dependent production of iNOS in intestinal epithelial cells, thereby protecting against colitis-associated tumorigenesis. We also propose that A20 plays a direct role in regulating NO-dependent cell death.
first_indexed 2024-04-11T17:32:05Z
format Article
id doaj.art-3c9d21c9040843689582793516145867
institution Directory Open Access Journal
issn 2772-5723
language English
last_indexed 2024-04-11T17:32:05Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Gastro Hep Advances
spelling doaj.art-3c9d21c90408436895827935161458672022-12-22T04:11:59ZengElsevierGastro Hep Advances2772-57232023-01-012196107A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated CancerDavid W. Basta0Mandy Vong1Adolat Beshimova2Brooke N. Nakamura3Iulia Rusu4Michael G. Kattah5Ling Shao6Division of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaDivision of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaDivision of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaDivision of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaDivision of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaDivision of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaCorrespondence: Address correspondence to: Ling Shao, MD, PhD, Division of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, 2011 Zonal Avenue, Hoffman Medical Research 600, Los Angeles, California 90033.; Division of Gastroenterology and Liver Disease, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CaliforniaBackground and Aims: Colon cancer can occur sporadically or in the setting of chronic inflammation, such as in patients with inflammatory bowel disease. We previously showed that A20, a critical negative regulator of tumor necrosis factor signal transduction, could regulate sporadic colon cancer development. In this report, we investigate whether A20 also acts as a tumor suppressor in a model of colitis-associated cancer. Methods: Colitis and colitis-associated tumors were induced in wild-type and A20 intestinal epithelial cell-specific knockout (A20dIEC) mice using dextran sodium sulfate and azoxymethane. Clinicopathologic markers of inflammation were assessed in conjunction with colonic tumor burden. Gene expression analyses and immunohistochemistry were performed on colonic tissue and intestinal enteroids. Nitric oxide (NO) production and activity were assessed in whole colonic lysates and mouse embryonic fibroblasts. Results: A20dIEC mice develop larger tumors after treatment with dextran sodium sulfate and azoxymethane than wild-type mice. In addition to elevated markers of inflammation, A20dIEC mice have significantly enhanced expression of inducible nitric oxide synthase (iNOS), a well-known driver of neoplasia. Enhanced iNOS expression is associated with the formation of reactive nitrogen species and DNA damage. Loss of A20 also enhances NO-dependent cell death directly. Conclusion: Mechanistically, we propose that A20 normally restricts tumor necrosis factor–induced nuclear factor kappa B–dependent production of iNOS in intestinal epithelial cells, thereby protecting against colitis-associated tumorigenesis. We also propose that A20 plays a direct role in regulating NO-dependent cell death.http://www.sciencedirect.com/science/article/pii/S277257232200156XColonUlcerative colitisInflammationNitric oxideA20Tnfaip3
spellingShingle David W. Basta
Mandy Vong
Adolat Beshimova
Brooke N. Nakamura
Iulia Rusu
Michael G. Kattah
Ling Shao
A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Gastro Hep Advances
Colon
Ulcerative colitis
Inflammation
Nitric oxide
A20
Tnfaip3
title A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
title_full A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
title_fullStr A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
title_full_unstemmed A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
title_short A20 Restricts NOS2 Expression and Intestinal Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
title_sort a20 restricts nos2 expression and intestinal tumorigenesis in a mouse model of colitis associated cancer
topic Colon
Ulcerative colitis
Inflammation
Nitric oxide
A20
Tnfaip3
url http://www.sciencedirect.com/science/article/pii/S277257232200156X
work_keys_str_mv AT davidwbasta a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer
AT mandyvong a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer
AT adolatbeshimova a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer
AT brookennakamura a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer
AT iuliarusu a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer
AT michaelgkattah a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer
AT lingshao a20restrictsnos2expressionandintestinaltumorigenesisinamousemodelofcolitisassociatedcancer